Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study

(Val)ganciclovir (vGCV) or foscarnet (FCN) as preemptive therapy (PET) for cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantation (HCT) is associated with myelosuppression and nephrotoxicity, respectively. We analyzed a cohort of CMV-seropositive (R(+)) HCT recipients managed pree...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Zavras, Phaedon, Su, Yiqi, Fang, Jiaqi, Stern, Anat, Gupta, Nitasha, Tang, Yuexin, Raval, Amit, Giralt, Sergio, Perales, Miguel Angel, Jakubowski, Ann A., Papanicolaou, Genovefa A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220837/
https://ncbi.nlm.nih.gov/pubmed/32315708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.03.019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky